Clinical Trials List
2014-06-01 - 2017-05-31
Phase III
Terminated9
ICD-10I82.90
Acute embolism and thrombosis of unspecified vein
ICD-10I82.91
Chronic embolism and thrombosis of unspecified vein
ICD-9453.9
Embolism and thrombosis of unspecified site
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 謝禮全 Division of Cardiovascular Diseases
- 盧炯睿 Division of Cardiovascular Diseases
- 陳業鵬 Division of Cardiovascular Diseases
- Shih-Sheng Chang Division of Cardiovascular Diseases
- 王宇澄 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- LIAN-YU LIN Division of Cardiovascular Diseases
- MAO-HSIN LIN Division of Cardiovascular Diseases
- 林俊立 Division of Cardiovascular Diseases
- 洪啟盛 Division of Cardiovascular Diseases
- CHO-KAI WU Division of Cardiovascular Diseases
- Tzung-Dau Wang Division of Cardiovascular Diseases
- 黃惠君 Division of Cardiovascular Diseases
- JYH-MING JIMMY JUANG Division of Cardiovascular Diseases
- 陳盈憲 Division of Cardiovascular Diseases
- - - Division of Cardiovascular Diseases
- 張博淵 Division of Cardiovascular Diseases
- 江福田 Division of Cardiovascular Diseases
- CHIA-TI TSAI Division of Cardiovascular Diseases
- Hsien Li Kao Division of Cardiovascular Diseases
- Yi-Chih Wang Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 黃少嵩 Division of Cardiovascular Diseases
- 吳承學 Division of Cardiovascular Diseases
- Shih-Hsien Sung Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 林立人 Division of Cardiovascular Diseases
- Ping-Yen Liu Division of Cardiovascular Diseases
- 黃成偉 Division of Cardiovascular Diseases
- Wei-Chuan Tsai Division of Cardiovascular Diseases
- 林志展 Division of Cardiovascular Diseases
- Po-Tseng Lee Division of Cardiovascular Diseases
- Yi-Heng Li Division of Cardiovascular Diseases
- Shih-Hung Chan Division of Cardiovascular Diseases
- 李文煌 Division of Cardiovascular Diseases
- 陳志鴻 Division of Cardiovascular Diseases
- Ting-Hsing Chao Division of Cardiovascular Diseases
- Ju-Yi Chen Division of Cardiovascular Diseases
- 李貽恆 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Po-Chao Hsu Division of Cardiovascular Diseases
- 林新進 Division of Cardiovascular Diseases
- 顏學偉 Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
- Hsiang Chun Lee Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
- Cheng-An Chiu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 吳炯仁 Division of Cardiovascular Diseases
- 鄭正一 Division of Cardiovascular Diseases
- 洪志凌 Division of Cardiovascular Diseases
- Shyh-Ming Chen Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
125 participants
-
Global
8520 participants
